Delivery Order SPE2DB22D3501-SPE2DB25FVL52
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,905.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,968,807 units of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a performance period extending until April 21, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $3,592.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a period of performance through April 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award, valued at $1,288.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,620,021 units of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $1,012.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is January 24, 2025. The contract does not have a set-aside designation, indicating open...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,700.80, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract is...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,418.94 and covers the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, through April 10, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $3,559.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,779,939 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of December 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,261.44, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of March 5, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $1,116.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone prop HFA 110 mcg 12gm, a pharmaceutical product, with a completion date of January 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,175.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with a completion date of July 2, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...